A Novel BCR::ABL1 Variant Detected with Multiple Testing Modalities
Chronic myeloid leukemia (CML) is associated with several breakpoint regions that result in different BCR::ABL1 fusion transcripts. These include the major breakpoint region (M-BCR), minor breakpoint region (m-BCR), and mu breakpoint region (u-BCR) corresponding to p210, p190, and p230 fusion transc...
Saved in:
| Main Authors: | J. Jean, M. Sukhanova, D. Dittmann, J. Gao, L. J. Jennings |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Case Reports in Hematology |
| Online Access: | http://dx.doi.org/10.1155/2024/8486267 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Precision Medicine in BCR-ABL1 Negative Myeloproliferative Neoplasms
by: Linet Njue, et al.
Published: (2020-12-01) -
Optimal Molecular Methods in Detecting p190BCR-ABL Fusion Variants in Hematologic Malignancies: A Case Report and Review of the Literature
by: Rebecca J. Sonu, et al.
Published: (2015-01-01) -
Prognostic Significance of Transcript-Type BCR‐ABL1 in Chronic Myeloid Leukemia
by: matteo molica, et al.
Published: (2020-08-01) -
Identification of rare atypical BCR-ABL1 transcript: A case report
by: Jayesh Saha, et al.
Published: (2023-07-01) -
Development of mirror-image monobodies targeting the oncogenic BCR::ABL1 kinase
by: Nina Schmidt, et al.
Published: (2024-12-01)